Global%20Venture%20Forum - PowerPoint PPT Presentation

About This Presentation
Title:

Global%20Venture%20Forum

Description:

Title: Global Venture Forum Last modified by: nagoshi Created Date: 5/6/2004 5:45:43 AM Document presentation format: Company – PowerPoint PPT presentation

Number of Views:211
Avg rating:3.0/5.0
Slides: 35
Provided by: iabm
Learn more at: https://www.iabmr.org
Category:

less

Transcript and Presenter's Notes

Title: Global%20Venture%20Forum


1
Global Venture Forum
  • -the most effective way to find business partners
    in Japan-

2
BIO Industry in Japan
Market Size
12.5 billion USD
(2001)
240.3 billion USD (2010)
Worldwide 2211.5 billion US
Source Overview of Biotechnology Strategy Council
USA 2884.6 billion US
USA 28.8 trillion US
Japan 240.3 billion US
Europe 115.3 billion US
Europe 19.2 trillion US
Japan 16.3 billion US
Japan 12.5 billion US
2001
2005
2010
2025
2003
3
The Bio Clusters in Japan

Source The number of bio- venture companies in
2003 by Japan Bioindustry Association

Hokkaido the number of bio-ventures 45
Kanto Region the number of bio-ventures 194
Kansai Region the number of
bio-ventures 77
4
Biotechnology Industry in the Kansai Region
  • Key Sectors
  • Pharmaceuticals
  • Medical Instruments
  • Functional Food

5
Potential for the Pharmaceutical Sector in Kansai
  • Pharmas in Kansai are concentrated in Osaka
    Doshomachi, the center of Osaka City.
  • 30 of Japans pharmaceutical-related companies
    and employees are concentrated in Kansai.
  • Number of pharmas in Kansai, are equivalent to
    that of U.K. or France.
  • Among the top 18 pharmas for sales in Japan, 8
    have their headquarters in Kansai.

6
The Top 18 Pharmas in Japan
By Amount of sales for drugs2003
  • 13. Ono Pharmaceutical
  • 14. Mitsubishi Pharma
  • 15. Sumitomo Pharmaceuticals
  • 16. GlaxoSmithKline
  • 17. Dainippon Pharmaceutical
  • 18. TAIHO Pharmaceutical
  • 1. Takeda Pharmaceutical
  • 2. Astellas (Yamanouchi Fujisawa)
  • 3. Sankyo Daiichi
  • 4. Eisai
  • 5. Shionogi
  • 6. Chugai Pharmaceutical
  • 7. Taisho Pharmaceutical
  • 8. Banyu Pharmaceutical
  • 9. Tanabe Seiyaku
  • 10. Otsuka Pharmaceutical
  • 11. Novartis Pharma
  • 12. Kyowa Hakko Kogyo

7
Foreign Affiliated Bio-related companies in Kansai
  • AstraZeneca Japan
  • Eli Lilly Japan
  • Schering-Plough K.K.
  • Bayer Japan
  • Boehringer Ingelheim
  • Schering
  • Organon Japan
  • Nihon Medi-Physics
  • Proctor Gamble

8
Concentration of Bio Research Institutions
  • Osaka University
  • (2,100 science researchers)
  • Osaka University Hospital and Faculty of
    Medicine
  • (advanced medical care1,000beds)
  • National Cardiovascular Center
  • (100 researchers, 700beds)
  • Osaka City University Medical School
  • Osaka City University Medical School Hospital
  • Osaka Bioscience Institute
  • (40 researchers)
  • Biomolecular Engineering Research Institute
  • (60 researchers)
  • Fundamental Technology Research Center for
  • Studies on the Creation of New Medicines
  • (more than 50 researchers)

9
High-leveled Researches
  • 1. Osaka University
  • 2. Kyoto University
  • 3. Okazaki National Research Institutes
  • 4. Kobe University
  • 5. Nagoya University
  • 6. National Institute of Genetics
  • 7. Tokyo University
  • 8. Kyushu University
  • 9. JICHI Medical School
  • 10. Kyoto Prefectural University of Medicine

10
Distinguished Researchers in Osaka
  • ltImmunology, Oncologygt
  • Tadamitsu KISHIMOTO, Osaka University
  • Toshio HIRANO, Osaka University
  • Shigekazu NAGATA, Osaka University
  • ltBiochemistry Neurosciencegt
  • Shigetada NAKANISHI, Kyoto University
  • ltBiochemistrygt
  • Yasutomi NISHIZUKA, Osaka University
  • Masashi YANAGISAWA, Texas University (former
    Kyoto University)
  • ltImmunology Molecular Cellgt
  • Tetsuya TAGA, Kumamoto University (former
    Osaka University Professor)
  • ltPharmacology Physiologygt
  • Tomoh MASAKI, Tsukuba University (former
    Kyoto University)

11
Focused Diseases
  • Arterial sclerosis
  • Ischemic heart disease
  • High-blood pressure
  • Arthritis rheumatoides
  • Asthma
  • Atopic dermatitis
  • Obesity
  • Diabetes

12
Market for the Medical Instrument Sector
Source Ministry of Health, Labor and Welfare
  • Market Size in Japan
  • 20 billion US (year 2002)
  • ? 2nd largest market in the world.

  • 80 billion US (year 2010)
  • Breakdown
  • ?medical-treatment related equipments 44.7
  • (PTCA catheter, pacemaker)
  • ?diagnostic device 31.3
  • (endoscope, CT, MRI)
  • ?others 24.0

13
Trends for Medical Care
  • Changes in the Population Structure
  • Aging Society
  • Changes in the Disease Structure
  • Acute Disease (infection)
  • Chronic Disease
  • (cancer, cardiac disorder,
  • cerebrovascular disease, diabetes)

14
Trends in Medical Care
  • Changes in the quality of medical care
  • examination treatment prevention
    of disease
  • curing technology
    Quality of Life

15
Focused types of medical instruments
Cardiovascular related
Regeneration related
Minimally invasive treatment
Bio- Imaging
Automotive diagnostic system Medical examination
16
Internationalization
  • Partnership with overseas companies
  • technical tie-ups
  • joint research and development

17
Application for patents for medical instruments
Number of applications for patents 11,537 (year
2000)
USA 64
Europe 27
Japan 9
18
Companies in Kansai
  • Nipro Corporation
  • SANYO Electric Biomedical
  • Toyobo Co., Ltd.
  • Teijin
  • Kaneka Corporation
  • Matsushita Electric Industrial Co., Ltd.
  • Shimadzu Corporation
  • OMRON Corporation
  • Kyocera Corporation

19
Market for the Functional Food Sector
  • Market Size in Japan
  • 4.2 billion USD (year
    2003)
  • 60 billion USD (year
    2010)
  • Source Ministry of
    Economy, Trade and Industry

20
Potential Market for the Functional Food Sector
21
Companies in Kansai
  • Suntory Limited
  • Gekkeikan
  • Glico
  • Ikari Sauce
  • Kaneka

22
OCCI Activities for promotion of Bio-industry
  • Study Group on Development of Functional Food
  • Japan Bio-technology Business Competition
  • BIO-Business School
  • FORUM for Industrialization of Next Generation
    Medical
  • Systems, Medical Treatment Systems
  • NANO-BIO Industrialization Seminars
  • BIO Information Highway Plan-Phase II
  • Bio-Delegation to USA (June 20-26, 2005)

23
Only Business Partnering event for foreign
companies in Japan
September 12th and 13th
24
The Simple Concept
CONNECT
25
Business Partnering Service
  • GVF Secretariat Pre-Arranges individual business
    meetings before the event.
  • Search and contact the best suited company -gt
    division -gt personnel for the presenting
    technology.
  • Nation-Wide promotion
  • 12. 2 meetings per
  • company (8.0 pre-arranged)

26
Whos in the Audience?
  • 161 Companies, 345 People (2004)
  • List of Participants from the past event
  • Asahi Chemical Industry Co.,Ltd.
  • Shimadzu Corporation
  • SUNTORY LTD.
  • Sekisui Chemical Co.,Ltd.
  • KANEKA Corporation
  • Sumitomo Chemical Co.,Ltd.
  • Hitachi Chemical Co.,Ltd.
  • Toyobo Co.,Ltd.
  • Kuraray Co.,Ltd.
  • Nippon Paint Co.,Ltd.
  • Nippon Shokubai Co.,Ltd
  • Takeda Chemical Industries,LTD.
  • SHIONOGI Co.,LTD.
  • Fujisawa Pharmaceutical Co.,Ltd.
  • Otsuka pharmaceutical Co.,Ltd.

27
Result of Individual Meetings
  • 7 companies concluded or about to conclude
    Contracts.
  • ( Technology tie ups, Joint Research, Joint
  • Development, Finance, etc)
  • 10 companies continues their business
    discussions.
  • 0 company had no specific result

28
Quality First
  • Only Companies with excellent technology are
    allowed to participate after the evaluation by
    Nominating Committee.
  • Main criteria
  • Creativity of Technology and Marketability of
    Products in Japan.

29
Success Stories from GVF03
  • Software company from USA made a distribution
    agreement with a major software distributor in
    Japan
  • Agribio company from Japan, producing UBS Soil
    Activator received investment from an industrial
    promotion organization in Japan.
  • A bio-tech company from Japan, developing
    innovative technology to develop oral agents for
    drugs considered difficult for oral absorption,
    received investment from an investment firm.

30
Process
  • Application Deadline
  • Screening Committee Meeting
  • Notification to Presenters
  • Audience Recruiting
  • Payment Deadline for Participation Fee
  • Presenters Orientation
  • GVF05-BIO

May 20th
June 20th
Mid-July
July 29th
September 11th
September 12th-13th
31
Participation Fee
  • US1,500-
  • ---The Fee Covers----
  • Business Match-making Service
  • Individual Booth ( W3.0 x L1.5 x H1.5 in meters )
  • Simultaneous Interpretation for Presentation
  • A Professional Interpreter for business talks for
    2days
  • Invitation to all GVF related events
  • Nation wide promotion

32
Incentives and a 1-Day Industrial Trip in Kansai
  • Incentives by the Osaka City Government
    (tentative)
  • For companies planning to set up a business
    base in
  • Osaka City, there is a chance to receive
    refund of the
  • GVF05 Participation Fee from the IBPC Osaka
    Investment
  • Promotion Center.
  • 1-Day Industrial Trip by METI-Kansai
  • (tentative)
  • The METI-Kansai is planning to hold another
    industrial trip
  • again for the GVF Participants after the
    GVF05-BIO event.

33
How to Apply
  • Submit necessary documentations to appropriate
    secretariat or coordinator via E-mail
  • Template file of Application form can be
    downloaded from the WEB http//www.gvf.ne.jp/
  • Attachment of Presentation helps

34
Thank you very much!!
For further details and questions Please contact
Ryoichi Nakanotel 81-6-6944-6403e-mail
gvf_at_osaka.cci.or.jp
http//www.gvf.or.jp/e
Write a Comment
User Comments (0)
About PowerShow.com